Why the study?
Does continuous intravenous lidocaine infusion improve paralytic ileus in patients with severe spinal cord injury resistant to neostigmine?
Does continuous intravenous lidocaine infusion improve paralytic ileus in patients with severe spinal cord injury resistant to neostigmine?
Continuous intravenous lidocaine infusion may be a treatment option for paralytic ileus resistant to neostigmine in patients with severe spinal cord injury.
Hypothesis-generating for lidocaine in neostigmine-resistant ileus after spinal cord injury; prospective trials needed before adoption.
Paralytic ileus is a major concern in the acute phase of spinal cord injury. Classical treatment with neostigmine is often ineffective. Continuous intravenous (i.v.) lidocaine infusion has been previously proposed intra and post-operatively in order to decrease the duration of post-operative ileus after abdominal surgery. We report the cases of seven patients suffering from complete paralytic spinal cord injury-related ileus with colectasy resistant to neostigmine, who were treated by i.v. lidocaine infusion.
No takes yet. Share an insight, caveat, or question.
Baumann et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: